Betaserc 8Mg | 100Tab

betaserc 8 mg tab

active ingredients

Betahistine dihydrochloride 8 mg tablets

indications

treatment of Ménière's syndrome

Dosage

Adults

Initial oral treatment is 8 to 16 mg three times daily, taken preferably with meals.

Maintenance doses are generally in the range 24 - 48 mg daily. Daily dose should not exceed 48 mg

symptoms of which may include vertigo, tinnitus, hearing loss and nausea.

Contraindications

Betahistine is contraindicated in patients with

• pheochromocytoma
•  hypersensitivity to the active substance
• There is no data available for patients with hepatic impairment.
• There is no data available for patients with renal impairment.
• There is limited data in the elderly, betahistine should be used with caution in this population.

 warnings and precautions for use

Caution is advised in the treatment of patients with peptic ulcer or a history of peptic ulceration, because of the occasional dyspepsia encountered in patients on betahistine.

Clinical intolerance to Betahistine may occur in bronchial asthma patients (see section 4.5 and 4.8) - These patients should therefore be monitored carefully during the treatment with betahistine.

Caution is advised in prescribing betahistine to patients with either urticaria, rashes or allergic rhinitis, because of the possibility of aggravating these symptoms.

Caution is advised in patients with severe hypotension.

Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

Pregnancy

There are insufficient data on the use of betahistine in pregnant women

Lactation

It is not known whether betahistine is excreted in breast milk in humans

Undesirable effects

Common: 

• headache
•  occasional drowsiness
• nausea
• hypersensitivity reactions
• vomiting
• gastrointestinal pain
• abdominal distension and bloating

storage

• Store below 30 °C.
• Store in the original package in order to protect from moisture